Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Goerlitz

4 clinical trials in Goerlitz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goerlitz at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Goerlitz

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Goerlitz

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and cardiovascular mortality reduction, evaluating innovative combination therapies using baxdrostat and dapagliflozin.

  • Heart Failure Prevention
  • Cardiovascular Death Risk Reduction
  • Combination Therapy Assessment

These trials aim to establish new standards in preventive cardiology and treatment outcomes.

02 Nephrology Studies

Innovative research examining treatments for chronic kidney disease combined with hypertension, investigating the effectiveness of medication combinations in preventing disease progression.

  • Kidney Function Preservation
  • Blood Pressure Management
  • Renal Outcome Assessment

The research focuses on improving long-term outcomes for patients with complex renal conditions.

03 Oncology and Thrombosis

Advanced clinical investigations studying venous thromboembolism in cancer patients, particularly focusing on gastrointestinal and genitourinary cancers, comparing abelacimab with established treatments.

  • Cancer-Associated Thrombosis
  • Comparative Treatment Efficacy
  • Bleeding Risk Management

These studies aim to enhance the management of thrombotic complications in cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.